Effect of Myofascial Release on Scoliotic Females With Dysmenorrhea.

NCT05817513 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-10-10

No results posted yet for this study

Summary

PURPOSE:

The purpose of this study is to determine the effect of myofascial release on spinal curvature, premenstrual symptoms, and quality of life in scoliotic females with dysmenorrhea

Conditions

  • Scoliosis Idiopathic Adolescent
  • Dysmenorrhea
  • Premenstrual Syndrome
  • Quality of Life

Interventions

OTHER

Myofascial release.

Myofascial release (MFR) is a therapeutic treatment that uses gentle pressure and stretching to facilitate the release of fascial restrictions caused by accidents, injury, stress, repetitive use, and traumatic or surgical scarring. The fascial restrictions are palpated by the practitioner and the techniques are applied directly to the skin of the patient without lotions or oils. The pressure is applied into the direction of the restriction just until resistance is felt or the tissue is perceived to stop moving. The pressure is sustained at this point of resistance, without sliding over the skin or forcing the tissue, for a minimum of 90-120s. As the tissue begins to release, the practitioner maintains the same amount of pressure and follows the release three dimensionally through multiple releases.

OTHER

Traditional exercises for scoliosis treatment.

The exercises are: 1. Pelvic tilt. 2. Arm and leg raises. 3. Cat-cow. 4. Bird dog. 5. Latismus dorsi stretch. 6. Abdominal press. 7. Practice a good posture. 8. Stretching and scapular exercises.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05817513 on ClinicalTrials.gov